TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/30/20 20:24 | 6/30/20 | TBIO | Translate Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shire Human Genetic Therapies, Inc. | MA | T | S | -141,141 | 20.68 | 0 | -6,825 | -100 | 0 | D | |||||||||||||||
6/5/20 09:52 | 6/3/20 | TBIO | Translate Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shire Human Genetic Therapies, Inc. | MA | T | S | -792 | 19.75 | 0 | -40 | -1 | 6,825 | D | |||||||||||||||
6/3/20 06:08 | 6/1/20 | TBIO | Translate Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shire Human Genetic Therapies, Inc. | MA | T | S.m | -4,237 | 19.81 | 0 | -214 | -3 | 6,865 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |